Juvenal Tobin W's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Aug 4, 2026
- Accession no.
- 0001628280-26-052648
- Filed
- Aug 4, 2026, 4:36 PM ET
- Trade date
- Jul 31-Aug 3, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $556.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Juvenal Tobin WCIK 0001856542 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock | SSaleDisposed | −8,149 | $28.84 | −$235,033.46 | 89,886 | Direct | |
| Jul 31, 2026 | Common Stock | SSaleDisposed | −7,270 | $29.58 | −$215,039.33 | 82,616 | Direct | |
| Jul 31, 2026 | Common Stock | SSaleDisposed | −1,891 | $30.26 | −$57,229.22 | 80,725 | Direct | |
| Aug 3, 2026 | Common Stock | SSaleDisposed | −1,730 | $28.25 | −$48,872.5 | 78,995 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.